AR101951A1 - Síntesis de ent-progesterona e intermediarios de la misma - Google Patents

Síntesis de ent-progesterona e intermediarios de la misma

Info

Publication number
AR101951A1
AR101951A1 ARP150102995A ARP150102995A AR101951A1 AR 101951 A1 AR101951 A1 AR 101951A1 AR P150102995 A ARP150102995 A AR P150102995A AR P150102995 A ARP150102995 A AR P150102995A AR 101951 A1 AR101951 A1 AR 101951A1
Authority
AR
Argentina
Prior art keywords
progesterone
ent
intermediaries
synthesis
same
Prior art date
Application number
ARP150102995A
Other languages
English (en)
Inventor
W Cran John
Emil Levy Daniel
Original Assignee
Prevacus Inc
The Florida State Univ Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevacus Inc, The Florida State Univ Res Found filed Critical Prevacus Inc
Publication of AR101951A1 publication Critical patent/AR101951A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/0805—Compounds with Si-C or Si-Si linkages comprising only Si, C or H atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5022—Aromatic phosphines (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005—Retrosteroids (9 beta 10 alfa)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente se refiere a la síntesis de ent-progesterona y a intermediarios de la misma. Reivindicación 1: Un método para preparar ent-progesterona, caracterizado porque el método comprende la etapa de (a) hacer reaccionar un compuesto de la fórmula (1) para formar un intermediario de tricetona de la fórmula (2), y b) ciclizar el compuesto de fórmula (2) para formar ent-progesterona.
ARP150102995A 2014-09-17 2015-09-17 Síntesis de ent-progesterona e intermediarios de la misma AR101951A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462051900P 2014-09-17 2014-09-17

Publications (1)

Publication Number Publication Date
AR101951A1 true AR101951A1 (es) 2017-01-25

Family

ID=55533837

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102995A AR101951A1 (es) 2014-09-17 2015-09-17 Síntesis de ent-progesterona e intermediarios de la misma

Country Status (20)

Country Link
US (1) US20160108081A1 (es)
EP (1) EP3194418B1 (es)
JP (1) JP2017535596A (es)
CN (1) CN108064228A (es)
AR (1) AR101951A1 (es)
AU (1) AU2015317651A1 (es)
BR (1) BR112017005167A2 (es)
CA (1) CA2961628A1 (es)
CL (1) CL2017000645A1 (es)
EA (1) EA201790428A1 (es)
ES (1) ES2910225T3 (es)
IL (1) IL251237A0 (es)
MA (1) MA39411A (es)
PH (1) PH12017500499A1 (es)
SG (1) SG11201702115SA (es)
TN (1) TN2017000088A1 (es)
TW (1) TW201619183A (es)
UY (1) UY36306A (es)
WO (1) WO2016044558A1 (es)
ZA (1) ZA201701976B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358248A (zh) * 2013-03-15 2016-02-24 佛罗里达州立大学研究基金有限公司 对映黄体酮及其中间产物的合成
IT201700004904A1 (it) * 2017-01-18 2018-07-18 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
GB202203328D0 (en) 2022-03-10 2022-04-27 Givaudan Sa Organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623071A (en) * 1948-05-13 1952-12-23 Synor Res Lab Inc Preparation of substituted cyclopentenones
JPS4926214A (es) * 1971-07-14 1974-03-08
US4189431A (en) * 1975-08-04 1980-02-19 The Board of Trustees of Leland Stanford Junior University Alkinyl terminating groups in biogenetic-like cyclizations to steroids
JP2001247562A (ja) * 2000-03-07 2001-09-11 Daicel Chem Ind Ltd アミド化合物及びその製造方法
CA2716095C (en) * 2008-02-26 2017-02-07 Emory University Steroid analogues for neuroprotection
WO2010088409A2 (en) 2009-01-30 2010-08-05 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
WO2012081736A1 (en) * 2010-12-17 2012-06-21 Mitsubishi Tanabe Pharma Corporation Continuous arycyclic compound
CN105358248A (zh) * 2013-03-15 2016-02-24 佛罗里达州立大学研究基金有限公司 对映黄体酮及其中间产物的合成

Also Published As

Publication number Publication date
EA201790428A1 (ru) 2017-08-31
MA39411A (fr) 2016-03-24
EP3194418A4 (en) 2018-12-12
JP2017535596A (ja) 2017-11-30
WO2016044558A1 (en) 2016-03-24
TW201619183A (zh) 2016-06-01
TN2017000088A1 (en) 2018-07-04
EP3194418A1 (en) 2017-07-26
CA2961628A1 (en) 2016-03-24
UY36306A (es) 2016-04-29
US20160108081A1 (en) 2016-04-21
IL251237A0 (en) 2017-05-29
PH12017500499A1 (en) 2017-08-30
AU2015317651A1 (en) 2017-04-06
ZA201701976B (en) 2019-06-26
CN108064228A (zh) 2018-05-22
BR112017005167A2 (pt) 2018-06-19
EP3194418B1 (en) 2021-12-15
CL2017000645A1 (es) 2018-09-14
SG11201702115SA (en) 2017-04-27
ES2910225T3 (es) 2022-05-12

Similar Documents

Publication Publication Date Title
CL2021000630A1 (es) Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585)
AR132627A2 (es) Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos
EA201692219A1 (ru) Способы получения противовирусных соединений
CL2016002455A1 (es) Anticuerpos multiespecíficos.
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
ECSP17042921A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
MX384794B (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles a partir de hexafluoropropeno.
MX2020013849A (es) Nuevos compuestos de sulfonilaminobenzamida como antihelminticos.
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
MX2018003903A (es) Compuesto biciclico y uso del mismo para inhibicion de suv39h2.
MX389099B (es) Proceso para la preparación de 3-cloro-2-vinilfenilsulfonatos.
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
MX2015016119A (es) Metodo para preparar derivados de 3,5-bis(fluoroalquil)pirazol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
AR105955A1 (es) Método para producir una piridinacarboxamida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal